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Background: Multiple variables have been shown to affect
early marginal bone loss (MBL). Among them, the location
of the microgap with respect to the alveolar bone crest, oc-
clusion, and use of a polished collar have traditionally been
investigated as major contributory factors for this early
remodeling. Recently, soft tissue thickness has also been in-
vestigated as a possible factor influencing this phenomenon.
Hence, this study aims to further evaluate the influence of
soft tissue thickness on early MBL around dental implants.
Methods: Electronic and manual literature searches were
performed by two independent reviewers in several data-
bases, including Medline, EMBASE, and Cochrane Oral
Health Group Trials Register, for articles up to May 2015
reporting soft tissue thickness at time of implant placement
and MBL with ‡12-month follow-up. In addition, random ef-
fects meta-analyses of selected studies were applied to ana-
lyze the weighted mean difference (WMD) of MBL between
groups of thick and thin peri-implant soft tissue. Metaregres-
sion was conducted to investigate any potential influences
of confounding factors, i.e., platform switching design,
cement-/screw-retained restoration, and flapped/flapless
surgical techniques.
Results: Eight articles were included in the systematic re-
view, and five were included in the quantitative synthesis and
meta-analyzed to examine the influence of tissue thickness
on early MBL. Meta-analysis for the comparison of MBL
among selected studies showed a WMD of -0.80 mm (95%
confidence interval -1.18 to -0.42 mm) (P <0.0001), favor-
ing the thick tissue group. Metaregression of the selected
studies failed to demonstrate an association among MBL
and confounding factors.
Conclusion: The current study demonstrates that implants
placed with an initially thicker peri-implant soft tissue have
less radiographic MBL in the short term. J Periodontol
2016;87:690-699.
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P
reservation of crestal marginal
bone remains one of the most de-
sired outcomes in implant den-
tistry.1 Traditionally, marginal bone loss
(MBL) <1.5 mm was defined as a refer-
ence point for successful implant treat-
ment after 1 year of loading.2 However,
with the use of new surface technolo-
gies and new implant designs and the
availability of new research on fac-
tors affecting bone remodeling,3 this
concept should be re-defined; having
1.5mm of MBL is no longer accept-
able during the first year in function. In
fact, a recent investigation has dem-
onstrated that 96% of implants with
MBL >2 mm during the first 18 months
presented with ‡0.44 mm bone loss
6 months postloading.4 This initial re-
modeling has traditionally been related
to a variety of factors, including inad-
equate occlusion,5 the presence of a mi-
crogap,6 use of an implant with a smooth
collar,7 infection,8 and more importantly,
soft tissue thickness and its influence
during re-establishment of the biologic
width.9
Progressive MBL around the implant
neck is a prelude to peri-implantitis de-
velopment.4 Hence, minimizing or pre-
venting this initial bone remodeling is of
paramount importance, starting at the
time of implant placement. With this
purpose in mind, many researchers have
tested the efficacy of different methods,
such as platform switching (PS),10* Department of Periodontics andOral Medicine, University ofMichigan School of Dentistry,
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different apico-coronal positions of the implant with
regard to the alveolar crest,11 and laser-modified
implant surfaces.12
Avoiding bone loss resulting from the presence
of a smooth implant neck can be as simple as posi-
tioning the machined area above the bone level.13
However, when aiming at distancing the microgap
away from the alveolar bone, several methods have
been investigated, namely, moving this implant–
abutment interface vertically and horizontally.10,11
Supracrestal positioning of 2 mm of the microgap
can minimize its influence on bone remodeling.11
Horizontally, the concept of PS was introduced by
Lazzara and Porter in 2006.10 It simply refers to
moving the implant–abutment connection inward, so
that the microgap is farther away horizontally from
the alveolar bone. The rationale resides in this mi-
crogap acting as a reservoir for bacterial colonization,
accumulating an inflammatory cell infiltrate that,
because of its proximity to the bone, may trigger
bone resorption.6,14-16 Hence, the farther away from
the crestal bone, the less influence on its stability.10
Accordingly, the concept of PS has been widely
studied during the last decade and shows promising
results.17-19 Multiple randomized controlled trials as
well as systematic reviews have confirmed its efficacy
in maintaining crestal bone.17,20,21
Nonetheless, most studies aiming at minimizing
early physiologic MBL by means of different tech-
niques lack proper analysis regarding mucosal thick-
ness at the time of implant placement.17-19 As early
as 1996, mucosal thickness was proven to be a sig-
nificant factor in marginal bone stability, when it was
demonstrated that if a minimal requirement for bio-
logic width (BW) formation is not satisfied, providing
enough surface for both junctional epithelium and
connective tissue attachments, bone resorption will
occur.9 Not surprisingly, a recent clinical trial in-
vestigated the influence of soft tissue thickness
on initial bone remodeling after fixture installation,
concluding that if a minimum 2 mm is not present
during Stage 1 surgery, bone resorption will occur
regardless of the use of laser-microtextured collars
and PS connections.22
This systematic review evaluates the influence of




Electronic and manual literature searches were
performed by two independent reviewers (FSLA
and AM) in several databases, including Medline,
EMBASE, and Cochrane Oral Health Group Trials
Register, for articles up to May 2015 in the English
language.
Patient, Intervention, Comparison, Outcome
(PICO) Question
P = healthy patients receiving ‡1 dental implants; I =
direct measurements of soft tissue thickness at time
of implant placement and radiographic MBL mea-
sured after implant placement with a minimum
follow-up of 12-months; C = influence of thick and thin
peri-implant soft tissue and other variables, if any, on
MBL; O = weighted mean difference (WMD) of MBL
between groups of thick and thin peri-implant soft
tissue; O1 = MBL; and O2 = significance of other
confounding factors for MBL (i.e., implant–abutment
design, surgical technique [flap versus flapless], and
type of restoration [screw versus cemented]).
Screening Process
Three major electronic databases were screened. For
the PubMed library, combinations of controlled terms
(MeSH and EMTREE) and keywords were used
whenever possible. In addition, other terms not in-
dexed as MeSH and filters were applied. As such, the
key terms used were: (((((((((dental implant[MeSH
Terms]) OR dental implantation[MeSH Terms]) OR
dental implants[MeSH Terms]) OR dental implanta-
tion, osseo-integrated[MeSH Terms]) AND marginal
bone loss[Title/Abstract]) OR crestal bone loss[Title/
Abstract]) AND tissue thickness[Title/Abstract]) OR
tissue biotype[Title/Abstract]) OR tissue phenotype
[Title/Abstract]) AND (Clinical Trial[ptyp] AND
Humans[Mesh])). Because of the limited number of
articles indexed following that strategy, a broader
screening was conducted at the same database:
((((((dental implants[Title/Abstract]) AND bone loss
[Title/Abstract]) OR marginal bone loss[Title/
Abstract]) OR crestal bone loss[Title/Abstract]) AND
soft tissue[Title/Abstract]) OR tissue thickness[Title/
Abstract] AND Humans[Mesh] AND (Clinical Trial
[ptyp] AND Humans[Mesh])). For EMBASE and
Cochrane, the key terms used were (Title, Abstract,
Keywords): ‘dental implant’/exp OR ‘dental implant’
AND (‘bone loss’/exp OR ‘bone loss’) AND (‘soft
tissue’/exp OR ‘soft tissue’) AND (‘thickness’/exp
OR ‘thickness’) OR (‘biotype’/exp OR ‘biotype’). The
screening in such databases was limited to ‘clinical
trials’ AND ‘humans.’ In addition, an electronic
screening of gray literature in the New York Academy
of Medicine Gray Literature Report was conducted as
recommended by A Measurement Tool to Assess
Systematic Reviews (AMSTAR).23
A manual search of periodontics-/implantology-
related journals, including Journal of Dental Re-
search, Journal of Clinical Periodontology, Journal
of Periodontology, and International Journal of
Periodontics & Restorative Dentistry, from January
2014 to May 2015 was also performed to ensure a
thorough screening process. References of all articles
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reviewed in full text were further screened to check all
available articles. Potential articles were examined
in full-text by two reviewers (FSLA and AM) indepen-
dently, and the articles’ eligibility for this review was
confirmed after discussion. The level of agreement
between the reviewers regarding study inclusion was
calculated using k statistics.
Eligibility Criteria
Articles were included in this systematic review if
they met the following criteria: 1) human prospective
and randomized controlled trials involving ‡10 im-
plants with a minimum follow-up of 12 months; 2)
only implants with rough surfaces were evaluated; 3)
studies had to report the soft tissue thickness at time
of implant placement, directly measured from the
implant site at the crest; and 4) comparison between
thin (<2 mm) and thick (‡2 mm) tissue groups in
terms of MBL measured radiographically at 12
months had to be reported. Case reports and case
series with <10 implants were excluded, and review
articles, retrospectives, animal studies, and studies
reporting <12-month results
were also excluded. Immediate
implants and implants with
completely machined surfaces
were not evaluated. Human
trials with missing information
were further excluded.
Statistical Analyses
Data were extracted by two ob-
servers (FSLA and AM) indepen-
dently, from the papers that met
inclusion criteria. If any disagree-
ment was found, another re-
viewer was consulted (HLW).
The difference of MBL around
implants with thin and thick
soft-tissue thickness at time of
implant placement was the
primary outcome. Pooled WMD
of MBL was estimated using
software.‡ The contribution
of each article was weighed.
Random effects meta-analyses
of the selected studies were
applied to avoid bias caused
by methodologic differences
among studies. Forest plots were
produced to graphically repre-
sent the difference in outcomes
of thin and thick tissue groups for
all included studies using im-
plants as the analysis unit. A P
value of 0.05 was used as the
level of significance. Heteroge-
neity was assessed with x2 test and I 2 test, with
ranges from 0% to 100%; lower values represent less
heterogeneity. To avoid bias from combining dif-
ferently designed studies, meta-analysis with the
same level (crestal or supracrestal) of implant place-
ment was performed in subgroups. In addition, funnel
plots were used to assess the presence of publi-
cation bias. Regression analysis was performed to
analyze the potential impact of confounding fac-
tors, including PS design, cement-/screw-retained
restoration, and flap/flapless surgical techniques,
on primary outcome. The reporting of these meta-
analyses adheres to the Preferred Reporting Items for
Systematic Review and Meta-Analyses statement
(Fig. 1).24
Quality Assessment
The quality of all selected randomized controlled trials
(RCTs) was assessed using the criteria modified from
Figure 1.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart of the
screening process in the databases.
‡ Review Manager, v.5.0, The Nordic Cochrane Centre, Copenhagen,
Denmark.
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the Cochrane Handbook for Systematic Reviews of
Interventions.25 Parameters evaluated included: 1)
appropriate population size; 2) definitions of in-
clusion and exclusion; 3) the presence of ran-
domization; 4) methods of allocation concealment;
5) masking of examiners; 6) incomplete outcome
data adequately addressed; and 7) free of sugges-
tion of selective outcome reporting. The potential
risk of bias was categorized as low if a study pro-
vided detailed information about all parameters
above. Moderate risk was considered if a study failed
to provide information on only one of the param-
eters, whereas if a study showed missing information
of >2 parameters, the study was categorized as
having a high risk of bias. All assessments were
completed by a single examiner (GL). The Newcastle-
Ottawa Scale was used to assess the quality of




Initial screening yielded a total of 335 articles (116
PubMed, 187 EMBASE, and 32 Cochrane). Addition-
ally, seven more articles were found through manual
screening. Overall, 161 potentially relevant articles
were selected after an evaluation of their titles and
abstracts. Full texts of these articles were obtained
and thoroughly evaluated. Of these, eight articles
fulfilled the inclusion criteria and were included in the
qualitative synthesis (Fig. 1; Table 1). A total of 34
articles were excluded. Articles along with reasons for
exclusion and references are listed in supplementary
Table 1 in online Journal of Periodontology. Of the
eight articles included in the systematic review, five
were also included in the quantitative synthesis and
meta-analyzed to extract the influence of the variables
onMBL. Details of all included studies are summarized
in Table 1. The k value for inter-reviewer agreement
for potentially relevant articles was 0.87 (titles and ab-
stracts) and 0.89 (full-text articles), indicating a consis-
tent agreement between the two reviewers.
Characteristics of Included Articles
Four articles are RCTs27-30 and four are comparative
controlled trials.22,31-33 Of the eight articles included,
three were further excluded from meta-analysis of
MBL for the following reasons: 1) no comparison
between thick and thin tissues (both groups presented
Figure 2.
Meta-analysis for the comparison of MBL among selected studies. For crestal placement, the WMD was -0.35 mm (95% CI: -0.98 to 0.28 mm) (P =
0.28). For supracrestal placement, the WMD was -1.29 mm (95% CI: -1.40 to -1.17 mm) (P <0.0001). For combined analysis, the WMD was
-0.80 mm (95% CI: -1.18 to -0.42 mm) (P <0.0001); this statistically significant difference favored the thick group.
Figure 3.
Funnel plot of meta-analysis of MBL among selected studies. MD = mean
difference.
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with thin mucosa);22 2) no comparison between thick
and thin tissues (both groups presented with thick
mucosa);30 and 3) no reporting of standard deviation
for MBL.31
Of the five articles included in themeta-analysis, four
used 2 mm as a cutoff point to divide between thin and
thick tissue,27-29,32 and one study used 3 mm.33 Two
articles29,32 divided tissue thickness into three different
categories: thin, thin (thickened), and thick. Both of
them used an allograft for increasing tissue thick-
ness at time of implant placement. For the purpose of
this review, both thickened groups were included and
analyzed together with the thick group, since tissue
thickness was >2 mm after augmentation. All in-
cluded articles used an internal connection system
with or without the use of a smaller platform (PS).
Meta-Analyses for MBL
Five studies27-29,32,33 reported data on MBL of implants
with thin and thick soft tissue. Of those five, two29,33
reported that the implants were placed at crestal bone
level; two27,32 at supracrestal bone level; and one28 at
both crestal and supracrestal bone levels. The statistical
results from each of the selected studies were converted
into effect sizes and combined in the meta-analysis.
For crestal placement, WMD was -0.35 mm, with
a 95% confidence interval (CI) of -0.98 to 0.28 mm
(P = 0.28). For supracrestal placement, theWMDwas
-1.29 mm (95% CI -1.40 to -1.17 mm) (P <0.0001).
Interestingly, for combined analysis, the WMD was
-0.80 mm (95% CI -1.18 to -0.42 mm) (P <0.0001),
and this statistically significant difference favored
the thick tissue group (Fig. 2). However, all com-
parisons presented considerable heterogeneity among
studies. For the crestal and supracrestal placement
subgroups and combined analyses, the P values for x2
test were <0.0001, 0.15, and <0.0001, respectively,
and I2 values were 99%, 47%, and 99%, representing
high, moderate, and high levels of heterogeneity
among the included studies. A funnel plot of meta-
analysis of MBL among selected studies is presented
in Figure 3.
Metaregression
Three confounding factors: 1) the use of platform
switching/matching designs; 2) cement-/screw-retained
restoration types; and 3) flap/flapless surgical tech-
niques were analyzed using metaregression. For MBL,
the confounding factors did not significantly influence
the outcome in any subgroup or combined analysis.
The P value of the metaregression for the use of dif-
ferent platform designs was 0.74, for cement-/
screw-retained restoration types was 0.25, and for
flapped/flapless surgical techniques was 0.35.
Quality Assessment
The results of risk of bias assessment for included
RCTs are summarized in Table 2. Three studies28-30
were considered to have a moderate risk of bias, and
one study27 was considered to have a high risk of
bias. Four studies22,31-33 were non-RCT, and hence,
were evaluated according to the Newcastle-Ottawa
Scale. The score obtained was 6.25 – 0.75, showing
an acceptable (low-medium risk of bias) methodo-
logic level of evidence.
Table 2.










Study type RCT RCT RCT RCT
Appropriate population size Y Y Y Y
Definitions of inclusions and exclusions Y Y Y Y
Presence of randomization Y Y Y Y
Methods of allocation concealment Y Y Y Y
Masking of examiners NR NR NR Y
Incomplete outcome data adequately
addressed
N Y Y NR
Free of suggestion of selective outcome
reporting
Y Y Y Y
Estimated potential risk of bias High Moderate Moderate Moderate
NR = not reported.
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DISCUSSION
As early as 1996, Berglundh and Lindhe demon-
strated in an animal study that a certain amount of
mucosal thickness is necessary to establish the so-
called BW around dental implants.9 If deficient,
crestal bone resorption will occur until enough space
is established for both connective tissue and junc-
tional epithelium.9 Although similar in composition
and structure, it has been shown that this attachment
apparatus is longer around dental implants com-
pared with natural dentition,34-36 resulting in the
requirement of more soft tissue height around im-
plant fixtures. Results from the current meta-analysis
confirmed previous observations demonstrating that
‡2 mm of soft tissue thickness is required for the
establishment of the BW, and that in the presence of
thin tissue (<2 mm), higher values of MBL will occur.
Multiple studies have previously supported the
hypothesis that implants with thin crestal mucosa
experience higher MBL.27,29,31 In addition to articles
included in this meta-analysis, it is worth mentioning
that investigations with different methodologies have
also supported the importance of having a thick mu-
cosa to preserve the crestal marginal bone. Galindo-
Moreno et al.37 and Vervaeke et al.38 concluded that
implants with longer abutments had less MBL. Al-
though both studies lacked measurements of tissue
thickness at the time of implant placement, it could
be hypothesized that longer abutments correspond
with thicker tissues and, hence, less MBL is ex-
pected.37,38 In fact, ‡2mm prosthetic abutment height
is the cutoff point for preservation of bone around
internal conical connection implants, data in accor-
dance with theminimal amount of soft tissue required
for establishment of BW and bone preservation sug-
gested in this meta-analysis.
The influence of PS abutment designs on MBL has
been widely investigated; however, the results are
controversial,20,39,40 and no clear conclusion could be
drawn at this point. Although clinical studies and
systematic reviews have reported potential beneficial
effects,17,20,39 multiple studies failed to demonstrate
any significant difference if thin mucosa (<2 mm) is
present.22,41 Accordingly, Vandeweghe and DeBruyn
concluded that PS is effective only when mucosal
thickness is enough for establishment of BW.42 In
their RCT, marginal bone preservation was signifi-
cantly different between PS and platform-matching
connections only when mucosa was >4.22 mm. In
this sense, Galindo-Moreno et al. recently reported
that vertical mismatching, in relation with prosthetic
abutment height, conditioned clinically by the kera-
tinized mucosa width, is better than PS in the pres-
ervation of MBL.43 Furthermore, results from a recent
investigation of implants restored with PS have
concluded that bone resorption is mainly related to
BW re-establishment rather than implant–abutment
horizontal mismatching.18 These studies shed light on
the potential correlation of peri-implant soft tissue
thickness and MBL.18,42,43 Interestingly, the influence
of peri-implant tissue thickness on MBL had never
been systematically reviewed previously. The results
of the current review confirm the beneficial effect on
reducing MBL with the presence of thicker tissue, and
this benefit outcome is more obvious when implants
are placed supracrestally, with the use of either PS or
platform-matched abutment connections.
To minimize early MBL as a consequence of lack of
mucosal thickness for re-establishment of attachment
apparatus at the time of implant placement, several
studies performed soft tissue grafting by means of
autogenous or allogeneic grafting materials to gain
tissue thickness.29,32,44 In 2010, Wiesner et al. per-
formed connective tissue grafting at the time of implant
placement in 10 partially edentulous patients.44 Results
at 12 months demonstrated better pink esthetic score
and similar MBL for the grafted group (0.8 mm) versus
non-grafted (0.6 mm), although differences were not
significant. The reason that significant differences
were not obtained might be a variety of different fac-
tors, including lack of baseline measurement for tissue
thickness, differences in graft size, and the protocol for
determining tissue thickness, which was measured at
10 mm below the alveolar crest. On the other hand,
Linkevicius et al.28 and Puisys and Linkevicius29 dem-
onstrated statistically significantly less MBL when thick
tissue or augmented thin tissues were present compared
with non-augmented thin tissues. Results from these
studies showed that tissues with >2 mm thickness, as
measured perpendicularly from the crest at the time of
implant placement,29,32 had less MBL.
In the subgroup analysis, the current review dem-
onstrates that peri-implant tissue thickness plays
a more important role in minimizing MBL when im-
plants are placed supracrestally rather than at the
level of the crest. The reason for this interesting out-
come might be the different location of the implant–
abutment interface (microgap) between implant body
and platform. Dibart et al. reported that an implant
placed at the crestal bone level approximated the
microgap to the bone, and thus MBL would occur
due to possible bacterial leakage.45 This abutment-
related inflammatory response could not be minimized
even with a thicker peri-implant tissue; therefore, the
MBL was significantly higher in crestal implant place-
ment than supracrestal implant placement. Piattelli
et al. suggested, in an animal model, that a more
apical position of the implant–abutment connection
implied a higher MBL than a more coronal position
due to closer proximity to the bone of the inflam-
mation zone associated with the implant–abutment
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interface.11 Consequently, supracrestal bone place-
ment lengthens the distance between microgap and
crestal bone, which might contribute to less MBL re-
ported in the subgroup analysis of the current review.
The following limitations of the current review are
noted. 1) The number of included papers for analyses
were low (n = 5). 2) There are certain degrees of
heterogeneity. Heterogeneity is related to the presence
of confounding factors within and among the selected
studies, for example, different study designs, follow-up
periods, and patient demographic data. None of the
included studies adjusted for the related confounding
factors. 3) Multiple factors might affect the changes
of MBL, such as smoking status, diabetes, and history
of periodontal disease. However, all the selected arti-
cles excluded patients with these conditions; therefore,
the meta-analysis of the current study may not be
generalizable. Additionally, most included stud-
ies introduced screw-retained restorations, which
also eliminated the influence of cement on MBL as
possible etiology.22,29,31-33 4) Most selected stud-
ies fulfilling the inclusion criteria were from the same
study group,22,27-29,31,32 which might increase the
potential bias of the study outcome. 5) Only one au-
thor performed the assessment of the quality of the
selected studies. 6) The current review includes only
studies written in English, which potentially introduces
selection bias. 7) Although initial circumferential bone
loss around the neck of the implants was assumed,46
MBL was assessed only at the mesial and distal as-
pects of implants, missing information about the effect
on the midfacial MB level. Future prospective studies
should include this aspect in the study design.
CONCLUSIONS
The current study demonstrates that implants placed
with an initially thicker peri-implant soft tissue have
less radiographic MBL in the short term. Hence, soft
tissue thickness evaluation at the time of implant
placement is strongly encouraged for clinicians and
researchers. In addition, with the presence of thin
tissue, the use of soft tissue grafting seems to mini-
mize the extent of peri-implant MBL.
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